vimarsana.com

Page 71 - இந்தியன் சபை க்கு மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Plea in SC for GST exemption on COVID-19 related drugs, medical equipment

Time to think of imposing lockdown like last year, asks Bombay HC

Avoid pen killers, patients can become serious if they have corona; Heart, diabetes or BP patients are not at high risk of having corona | दर्द या बुखार होने पर पेन किलर्स से बचें, कोरोना होने पर सीरियस हो सकते हैं मरीज; दिल, डायबिटीज और बीपी के मरीजों के लिए भी खास सलाह

Avoid pen killers, patients can become serious if they have corona; Heart, diabetes or BP patients are not at high risk of having corona | दर्द या बुखार होने पर पेन किलर्स से बचें, कोरोना होने पर सीरियस हो सकते हैं मरीज; दिल, डायबिटीज और बीपी के मरीजों के लिए भी खास सलाह
bhaskar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhaskar.com Daily Mail and Mail on Sunday newspapers.

Serum Institute brings Covishield procurement price for states down to Rs 300

New Delhi, April 28 Serum Institute of India said it was reducing its vaccine Covishield’s procurement price for states from Ra 400 to Rs 300 a dose a development that comes after India’s vaccine makers faced backlash over their prices as registration opened for people over 18. SII’s Chief Executive Office Adar Poonawalla said in a tweet that the company, one of  India’s leading vaccine maker, had brought down the price of the Oxford vaccine after a meeting with the central government. “As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives,” the tweet said.

Researchers to study Indomethacin s impact on oxygen need in Covid patients

Researchers to study Indomethacin’s impact on oxygen need in Covid patients April 28, 2021 × After seeing encouraging results in a pilot study done last year, Indian researchers are now planning to conduct a randomised control trial (RCT) to understand the efficacy and safety of indomethacin in providing faster symptomatic relief and reduction in oxygen requirement in Covid-19 patients. Indomethacin is a nonsteroidal, anti-inflammatory drug (NSAID) commonly used to reduce fever, pain, stiffness, and swelling caused by rheumatoid arthritis. In December 2020, Medrxiv published a preprint of a study conducted by a group of doctors, who advanced the case use of Indomethacin for faster symptomatic relief and preventing progression of pneumonia in Covid-19 patients.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.